These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23775050)

  • 1. Pediatric generalized anxiety disorder: predictors of outcome after selective serotonin reuptake inhibitor monotherapy.
    Masi G; Mucci M; Pfanner C; Berloffa S; Liboni F; Perugi G
    J Clin Psychopharmacol; 2013 Aug; 33(4):577-9. PubMed ID: 23775050
    [No Abstract]   [Full Text] [Related]  

  • 2. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.
    Hedges DW; Brown BL; Shwalb DA; Godfrey K; Larcher AM
    J Psychopharmacol; 2007 Jan; 21(1):102-11. PubMed ID: 16714326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivors of torture presenting at an anxiety disorders clinic: symptomatology and pharmacotherapy.
    Bouwer C; Stein DJ
    J Nerv Ment Dis; 1998 May; 186(5):316-8. PubMed ID: 9612450
    [No Abstract]   [Full Text] [Related]  

  • 4. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow B; Baldwin DS; Dolberg OT; Andersen HF; Stein DJ
    J Clin Psychiatry; 2006 Sep; 67(9):1428-34. PubMed ID: 17017830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxious depression and response to treatment.
    Nelson JC
    Am J Psychiatry; 2008 Mar; 165(3):297-9. PubMed ID: 18316424
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials.
    Rynn MA; Riddle MA; Yeung PP; Kunz NR
    Am J Psychiatry; 2007 Feb; 164(2):290-300. PubMed ID: 17267793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily venlafaxine XR compared with fluoxetine in outpatients with depression and anxiety.
    Judge R; Wagner BE
    J Clin Psychiatry; 1999 Nov; 60(11):795-6. PubMed ID: 10584775
    [No Abstract]   [Full Text] [Related]  

  • 8. Does a preexisting anxiety disorder predict response to paroxetine in irritable bowel syndrome?
    Masand PS; Gupta S; Schwartz TL; Kaplan D; Virk S; Hameed A; Lockwood K
    Psychosomatics; 2002; 43(6):451-5. PubMed ID: 12444227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of depressive symptom trajectories in a prospective follow-up of late adolescents.
    Coryell W; Mills J; Dindo L; Calarge CA
    Psychol Med; 2020 Oct; 50(13):2283-2288. PubMed ID: 31576781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obsessive compulsive disorder is not an anxiety disorder.
    Montgomery SA
    Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():57-62. PubMed ID: 8254154
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitor use in the treatment of the pediatric non-obsessive-compulsive disorder anxiety disorders.
    Seidel L; Walkup JT
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):171-9. PubMed ID: 16553537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis.
    Strawn JR; Welge JA; Wehry AM; Keeshin B; Rynn MA
    Depress Anxiety; 2015 Mar; 32(3):149-57. PubMed ID: 25449861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline.
    Ball SG; Kuhn A; Wall D; Shekhar A; Goddard AW
    J Clin Psychiatry; 2005 Jan; 66(1):94-9. PubMed ID: 15669894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study.
    Rickels K; Zaninelli R; McCafferty J; Bellew K; Iyengar M; Sheehan D
    Am J Psychiatry; 2003 Apr; 160(4):749-56. PubMed ID: 12668365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder.
    Stein DJ; Stein MB; Goodwin W; Kumar R; Hunter B
    Psychopharmacology (Berl); 2001 Nov; 158(3):267-72. PubMed ID: 11713616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial.
    Lenze EJ; Mulsant BH; Shear MK; Dew MA; Miller MD; Pollock BG; Houck P; Tracey B; Reynolds CF
    Am J Psychiatry; 2005 Jan; 162(1):146-50. PubMed ID: 15625213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conclusions inconsistent with results with citalopram.
    Kruszewski SP
    Am J Psychiatry; 2005 Nov; 162(11):2195-6; author reply 2196-7. PubMed ID: 16263873
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective serotonin reuptake inhibitors in the treatment of paediatric anxiety disorders: a review.
    Murphy TK; Bengtson MA; Tan JY; Carbonell E; Levin GM
    Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S47-63. PubMed ID: 11110019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder.
    Strawn JR; Prakash A; Zhang Q; Pangallo BA; Stroud CE; Cai N; Findling RL
    J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):283-93. PubMed ID: 25791145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.
    Sonawalla SB; Spillmann MK; Kolsky AR; Alpert JE; Nierenberg AA; Rosenbaum JF; Fava M
    J Clin Psychiatry; 1999 Sep; 60(9):580-3. PubMed ID: 10520975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.